To get your productivity back on track you must use your energy wisely, whether it’s running on fumes or stockpiled from vacation. Some ways to turn the end of summer into a springboard for a productive Autumn are outlined below.
Image Credit: DS InPharmatics
The main reason that a biotech company fails is rarely because of bad products, unsuccessful biotech companies usually fail for the same reason that many businesses fail: They do not have a strong strategic development plan (SDP).
The problem can typically be traced to failing to adapt to changing business needs and evolving regulations if a biotech company has a Chemistry, Manufacturing and Controls (CMC) plan and the program still fails.
CMC Regulatory compliance is making sure that all of the required CMC practices are performed in agreement with regulatory agencies’ expectations and needs. CMC regulatory compliance helps to make sure that all CMC practices are updated accordingly, since such requirements and expectations change with time.
Furthermore, CMC Regulatory compliance determines that appropriate CMC practices are performed if the company has made any CMC specific commitments to the regulatory agencies, either in writing or verbally.
Some key elements that every biotech manufacturer and developer should consider improving for their success are outlined below:
Market
In order to remain relevant every business must understand its market. A plan for gathering feedback and agreement about the regulatory expectation as it changes can help you connect how your strengths can meet the most crucial requirements.
Position
To increase awareness of issues that undermine the company in some way, it is important to understand your company’s position and its strengths and weaknesses. It is possible to plan to overcome any obstacles to success from within and create better overall operating procedures using this knowledge.
Goals
Without short-term and long-term goals you cannot have a strategy. Plans based on your goals will serve as guidelines for all future decisions once you better understand your company’s position and the regulatory expectations.
Deadlines
Investors expect results that remain within budget and are on-time. The SDP should include special techniques for meeting project deadlines, like hiring temporary technical consultants and other experts to help with management, submission, R&D, and technical writing and/or FDA-related matters.
Resources
The SDP must take critical resources, such as money, investors, technologies (Process and Product Control) and people into account. Your strategy should focus on optimal ways to optimize these resources in a cost-effective and efficient way while still maintaining high standards in every area. You must also plan for future resource needs.
Quality
Good quality control leads to a more streamlined process and a better work atmosphere where all staff and development partners are more motivated to stay with your business and increase their productivity.
A strategic development plan should cover every aspect of the biotech process, including manufacturing, chemistry, and regulatory compliance. The crucial elements discussed in this article are the strong foundation on which all the rest is built.
Acknowledgments
Produced from materials originally authored by Edward A. Narke from Design Space InPharmatics.
About DS InPharmatics 
DS InPharmatics (DSI) provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.
Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence. Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.
In April 2021 we were thrilled to announce that DSI has just become part of ProductLife Group.
French-headquartered ProductLife Group (PLG) is well-known in the Life Sciences market. It has a track record of successfully managing global outsourcing programs and insourcing services for its international client base. The company is on a mission to help transform human health outcomes by optimizing regulatory affairs, safety & vigilance, and quality compliance for life sciences organizations worldwide.
The fit between our two organizations could not be more perfect. We will complement PLG's growing biotech services portfolio. US biotech sponsors recognize DSI as a leader in consulting for go-to-market strategies and RA pre-market consulting. At the same time, PLG has a strong reputation for managing end-to-end outsourcing of regulatory affairs and pharmacovigilance activities worldwide.
Our merger with PLG will harness our combined strengths, offering our clients on both sides of the Atlantic support with their developed drugs approvals and post-approvals compliance, plus advisory services on the best market strategies to deliver a rapid ROI on their development. Together we will offer our clients increased pharmacovigilance capabilities - including a QPPV; pharmacovigilance consulting; and a fully validated safety database - as well as complementary toxicology-related services; RIM/electronic document management services; and support for medical device regulatory requirements.
We see enormous potential in this new chapter for DSI and you, our clients. As a PLG company, we have the opportunity to become part of a global force in life sciences regulatory and compliance solutions and services, and we're incredibly excited to add our momentum to that effort.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.